3393 Total Publications
Enriching the design of Alzheimer's disease clinical trials: Application of the polygenic hazard score and composite outcome measures
Banks, SJ, Qiu, Y, Fan, CC, Dale, AM, Zou, J, Askew, B and Feldman, HH
PMCID:7507583
; 2020; Journal Alzheimers Dement (N Y); vol. 6; no. 1; pp. e12071;
Improved Risk Stratification for Progression from Mild Cognitive Impairment to Alzheimer's Disease with a Multi-Analytical Evaluation of Amyloid-β Positron Emission Tomography
Beyer, L, Brendel, M, Scheiwein, F, Sauerbeck, J, Hosakawa, C, Alberts, I, Shi, K, Bartenstein, P, Ishii, K, Seibyl, J, Cumming, P and Rominger, A
2020; Journal J Alzheimers Dis; vol. 74; no. 1; pp. 101-112;
GenEpi: gene-based epistasis discovery using machine learning
Chang, YC, Wu, JT, Hong, MY, Tung, YA, Hsieh, PH, Yee, SW, Giacomini, KM, Oyang, YJ and Chen, CY
2020; Journal BMC Bioinformatics; vol. 21; no. 1; pp. 68;
Abnormal dynamic functional connectivity in Alzheimer's disease
Gu, Y, Lin, Y, Huang, LL, Ma, JJ, Zhang, JB, Xiao, Y, Dai, ZJ and Alzheimers Dis, N
2020; Journal Cns Neuroscience & Therapeutics; vol. 26; no. 9; pp. 962-971;
Predictive Value of (18)F-Florbetapir and (18)F-FDG PET for Conversion from Mild Cognitive Impairment to Alzheimer Dementia
Blazhenets, G, Ma, Y, Sörensen, A, Schiller, F, Rücker, G, Eidelberg, D, Frings, L and Meyer, PT
PMCID:6723529
; 2020; vol. 8; no. 8;
Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation
Ewers, M, Biechele, G, Suárez-Calvet, M, Sacher, C, Blume, T, Morenas-Rodriguez, E, Deming, Y, Piccio, L, Cruchaga, C, Kleinberger, G, Shaw, L, Trojanowski, JQ, Herms, J, Dichgans, M, Brendel, M, Haass, C and Franzmeier, N
PMCID:7507349
; 2020; Journal EMBO Mol Med; vol. 12; no. 9; pp. e12308;